Natco Pharma Limited Everolimus Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Everolimus Export Records India — #1 Exporter, 223 Shipments, $11.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Everolimus

India Pharmaceutical Trade Intelligence

$37.9M87 Suppliers67 CountriesHS 30049049

ExportsIndia → UNITED STATES50.5%India → GERMANY15.7%

ImportsSWITZERLAND → India$2.8M UNITED STATES → India$346.7K

#1 Supplier: NATCO PHARMA #1 Buyer: ASCEND GMBH

Natco Pharma Limited — Everolimus Exporter #1 | $11.2M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Everolimus Exporter Profile

Indian Pharmaceutical Exporter · #1 for Everolimus · $11.2M export value · DGFT Verified

Natco Pharma Limited is the #1 Indian exporter of Everolimus with $11.2M in export value and 223 verified shipments. Natco Pharma Limited holds a 29.4% market share in Everolimus exports across 8 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Everolimus Export Profile: Buyers & Destinations

Natco Pharma Limited Everolimus export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Everolimus?

Country	Value	Shipments	Share
UNITED STATES	$4.6M	139	57.0%
MALTA	$1.8M	45	22.6%
BRAZIL	$1.0M	21	12.9%
SAUDI ARABIA	$300.0K	6

Who Are the Top Buyers of Everolimus from Natco Pharma Limited?

Buyer	Country	Value	Orders
BRECKENRIDGE PHARMACEUTICAL INC	UNITED STATES	$2.2M	63
PHARMACARE PREMIUM	MALTA	$1.8M	45
BRECKENRIDGE PHARMACEUTICAL, INC	UNITED STATES	$883.3K	21
BRECKENRIDGE PHARMACEUTICAL	UNITED STATES	$758.9K	21
NATCOFARMA DO BRASIL LTDA,	BRAZIL	$550.0K	11
BRECKENRIDGE PHARMACEUTICALS INC	UNITED STATES	$350.0K	7
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$300.0K	6
CARDINAL AMBIENT &	UNITED STATES	$287.2K	24
BRECKENRIDGEPHARMACEUTICAL INC	UNITED STATES	$280.8K	6
NATCO FARMA DO BRASIL LTDA	BRAZIL	$150.0K	3

Natco Pharma Limited supplies Everolimus to 17 buyers globally. The largest buyer is BRECKENRIDGE PHARMACEUTICAL INC (UNITED STATES), followed by PHARMACARE PREMIUM (MALTA) and BRECKENRIDGE PHARMACEUTICAL, INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Everolimus Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
EVEROLIMUS 10MG TABLETS 28'S (OTHER REFE	$200.0K	4
EVEROLIMUS 0.5MG TABLETS 60S (4952X 60S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:123270)NOS	$165.3K	6
EVEROLIMUS TABLETS 10 MG (BULK)(OTHER REFERENCE CI NO: 123255)(RODTEP ENTRY NO:10112)NOS	$150.0K	3
EVEROLIMUS TABLETS 10 MG (BULK) (OTHER REFERENCE CI NO:124002)(RODTEP ENTRY NO:10112)	$150.0K	3
EVEROLIMUS 10MG TABLETS 28'S (913X28'S)(APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REF(S)CINO:124040)	$150.0K	3
EVEROLIMUS TABLETS 5 MG (BULK)(OTHER REFERENCE CI NO: 123255)(RODTEP ENTRY NO: 10112)NOS	$148.6K	3
EVEROLIMUS 5MG TABLETS 28'S (1249X28'S)(APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S)CI NO:123272)NOS	$148.6K	3
EVEROLIMUS 10MG TABLETS 28S (1171 X 28S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:123243)NOS	$138.7K	3
EVEROLIMUS TABLETS 5 MG (BULK) (OTHER RE	$100.0K	2
EVEROLIMUS 10MG TABLETS 28 S APPENDIX 4R RODTEP ENTRY NO 10112 OTHER REFERENCE S CI NO 122283	$100.0K	2

Natco Pharma Limited exports 179 distinct Everolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EVEROLIMUS 10MG TABLETS 28'S (OTHER REFE with 4 shipments worth $200.0K.

How Does Natco Pharma Limited Compare to Nearest Everolimus Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	NATCO PHARMA LIMITED ★	$11.2M	223	8	$50.0K
2	ALKEM LABORATORIES LIMITED	$4.8M	95	4	$50.0K
4	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$750.0K	15	8	$50.0K

Natco Pharma Limited ranks #1 among 87 Indian Everolimus exporters. Average shipment value of $50.0K compared to the market average of $205.9K. The closest competitors by value are ALKEM LABORATORIES LIMITED and BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED.

Which Indian Ports Ship Everolimus Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	91	14.7%
HYDERABAD AIR	91	14.7%
SAHAR AIR	79	12.7%
HYDERABAD ACC (INHYD4)	61	9.8%
DELHI AIR	43	6.9%
NHAVA SHEVA SEA (INNSA1)	29	4.7%
ACC SHAMSHABAD AIRPO	23	3.7%
Bombay Air	20	3.2%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Everolimus Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Everolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 223 individual customs records matching Natco Pharma Limited exporting Everolimus, covering 179 formulations to 9 countries via 17 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 67+ countries, 135+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Everolimus

Everolimus

Natco Pharma Limited — Everolimus Exporter Profile

Natco Pharma Limited — Everolimus Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Everolimus?

Who Are the Top Buyers of Everolimus from Natco Pharma Limited?

What Is India's Total Everolimus Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Everolimus Exports?

How Does Natco Pharma Limited Compare to Other Indian Everolimus Exporters?

What Everolimus Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Everolimus to Key Markets

United States — FDA

Brazil — ANVISA

How Does Natco Pharma Limited Compare to Nearest Everolimus Exporters?

Which Indian Ports Ship Everolimus Exports?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Everolimus Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Everolimus Export Data from Natco Pharma Limited

Everolimus Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source